Free Trial
→ Now that Trump’s be inaugurated, this day will be key (mark your calendar) (From Timothy Sykes) (Ad) Free KROS Stock Alerts

Keros Therapeutics (KROS) SEC Filings & 10K Form

Keros Therapeutics logo
$11.40 -0.31 (-2.65%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$11.40 0.00 (0.00%)
As of 01/31/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Keros Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
01/30/2025
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:15 PM		Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
Form 4/A
01/21/2025
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
5:31 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:00 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
5:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
6:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:02 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:18 PM		CHYUNG YUNG H. (Reporting)
Keros Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
3:22 PM		Keros Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:02 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:00 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:06 PM		GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:01 PM		Keros Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:12 PM		Keros Therapeutics (Subject)
ORBIMED ADVISORS LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:02 PM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:15 PM		Keros Therapeutics (Filer)
Form 424B5
06/17/2024
4:17 PM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
5:07 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:10 PM		BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2024
3:11 PM		BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
3:15 PM		Farzan Nima (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		GRAY MARY ANN (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Keros Therapeutics (Issuer)
Knowles Julius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Keros Therapeutics (Issuer)
Nussbaum Ran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Kariv Tomer (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:15 PM		Keros Therapeutics (Issuer)
Seth Alpna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:03 AM		Keros Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
7:00 AM		Keros Therapeutics (Filer)
Form S-3ASR
03/14/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:01 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:02 AM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
3:02 PM		Keros Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
New crypto boom will be greatest in history (Ad)

Urgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is the moment American crypto investor’s have been waiting for."

Click here now for full details. 
02/15/2024
7:37 PM		Cooper Simon Peter (Reporting)
Keros Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:38 PM		Keros Therapeutics (Issuer)
Rovaldi Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:40 PM		Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:41 PM		Keros Therapeutics (Issuer)
Seehra Jasbir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:38 PM		ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Keros Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:16 AM		FMR LLC (Filed by)
Keros Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:KROS) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners
Elon’s #1 AI Stock” SET TO SOAR
Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.
Behind the Markets | Sponsored
Now that Trump’s be inaugurated, this day will be key (mark your calendar)
Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...
Timothy Sykes | Sponsored
Will DeepSeek pop the AI bubble?
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
Better than Bitcoin – and potentially more profitable
The world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...
Brownstone Research | Sponsored
Trump vs. Texas
Ever since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...
Stansberry Research | Sponsored
Turning Panic Into Opportunity
AI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...
Weiss Ratings | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored
Will Elon trigger another AI flash crash?
AI continues to dominate financial headlines in 2025...
Altimetry | Sponsored